The cure rate of leukemia m5 patients can reach about 60% if they have received timely and effective treatment. Leukemia m5 can also be referred to as acute mononuclear cell leukemia, which can generally be treated with allogeneic hematopoietic stem cell transplantation and systemic drug chemotherapy. Specific drugs include cytarabine, Zoerythromycin and so on. 1. Acute mononuclear cell leukemia is one of the more difficult to treat myeloid leukemias. If the patient is in good health, after induction therapy to achieve remission, timely hematopoietic stem cell transplantation, about 60% of patients can be cured (progression-free survival for more than 5 years). 2. However, if the patient is old and weak or unable to undergo allogeneic HSCT, the cure rate is lower and the prognosis is worse. It is recommended to receive regular treatment under the guidance of doctors according to the patient’s own physical condition to improve the cure rate.